Scale molecular variant interpretation without expanding staff

Molecular oncology laboratories face mounting pressure as expanding sequencing capabilities produce increasingly complex variant profiles that demand extensive interpretation. At the same time, growing testing volumes and limited specialized staff create bottlenecks in variant curation, evidence review and report generation. Ensuring accurate, consistent reports while keeping pace with evolving guidelines and delivering timely results has become a major operational challenge.

That’s why leading laboratories rely on QCI Precision Insights (formerly N-of-One), a professional clinical variant interpretation service built for molecular oncology: 

• Trusted, reliable expertise: A dedicated team of PhD scientists and consulting oncologists transforms complex biomarker data into clear, clinically actionable insights—complete with report-ready content for physicians. 
• Grounded in real-world evidence: Interpretations are supported by FDA drug labels, practice guidelines, clinical trials, and peer-reviewed literature to ensure comprehensive clinical context. 
• Confidence for physicians, better care for patients: Deliver the insights oncologists need to make faster, more informed treatment decisions—helping patients receive the right therapy at the right time. 

Join the webinar: Discover how QCI Precision Insights helps laboratories tackle their most complex reporting challenges and deliver reports that truly support clinical care.